MAb159, a high-affinity GRP78-specific mouse monoclonal IgG antibody potently suppressed PI3K/AKT signaling, tumor growth, metastasis, and synergized with topoisomerase inhibitor (106). This evidence concerns the gene AKT1 and neoplasm.